Effect of clopidogrel on platelet aggregation and intimal hyperplasia following carotid endarterectomy in the rat

Vascular

Volumn 13, Issue 1, 2005, Pages 43-49

  Bledsoe, Shelly L ^a   Brown, Aliza T ^a   Davis, Joseph A ^a   Chen, Hongjiang ^a   Eidt, John F ^a   Moursi, Mohammed M ^a  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Clopidogrel; Intimal hyperplasia; Platelet activity; Platelet aggregation

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HOMOCYSTEINE; PLACEBO;

ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; BOLUS INJECTION; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; INHIBITION KINETICS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; TREATMENT OUTCOME;

EID: 14644433698     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1258/rsmvasc.13.1.43     Document Type: Article

References (26)

1. Herbert JM, Tissinier A, Defreyn G, Maffrand JP. Inhibitory effects of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits. Arterioscler Thromb 1993; 13:1171-9.
2. Wolfe JH, Taylor PR, Cheshire NJ. Graft surveillance - a biased overview. In: Greenhalgh RM, Hollier LH, editors. The maintenance of arterial reconstruction. 1st ed. London: WB Saunders Company; 1991. p. 119-27.
3. Clowes AW. Pathologic intimal hyperplasia as a response to vascular injury and reconstruction. In: Rutherford RB, Cronenwett JL, Gloviczki P, et al, editors. Vascular surgery. Vol 1. 5th ed. Philadelphia: WB Saunders Company; 2000. p. 408-18.
4. Mattos MA, van Bemmelen PS, Barkmeier LD, et al. Routine surveillance after carotid endarterectomy: does it affect clinical management? J Vasc Surg 1993;17:819-31.
5. Gray BH, Sullivan TM, Childs MB, et al. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg 1997;25:74-83.
6. Di Minno G, Cerbone AM, Mattioli PM, et al. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. J Clin Invest 1985;75:328-38.
7. Quinn MJ, Fitzgerald DJ. Ticlopidine and clopidogrel. Circulation 1999;100:1667-72.
8. Gurbel PA, Malinin AI, Callahan KP, et al. Effect of loading with dopidogrel at the time of coronary stenting on platelet aggregation and glycoprotein IIb/IIIa expression and platelet-leukocyte aggregate formation. Am J Cardiol 2002;90:312-5.
9. Bernat A, Mares AM, Defreyn G, et al. Effect of various antiplatelet agents on acute arterial thrombosis in the rat. Thromb Haemost 1993;70:812-6.
10. Southern F, Eidt J, Drouilhet J, et al. Increasing levels of dietary homocystine with carotid endarterectomy produced proportionate increases in plasma homocysteine and intimal hyperplasia. Atherosclerosis 2001;158:129-38.
11. Leoncini G, Pascale R, Signorello MG. Effects of homocysteine on L-arginine transport and nitric oxide formation in human platelets. Eur J Cin Invest 2003;33:713-9.
12. Brown AT, Smith TP, Cruz CP, et al. Intimal hyperplasia following carotid endarterectomy in an insulin-resistant rat model. Metabolism 2003;52:834-9.
13. Law MM, Gelabert HA, Moore WS, et al. Cigarette smoking increases the development of intimal hyperplasia after vascular injury. J Vasc Surg 1996;23:401-9.
14. Ubbink J, Hayward VW, Bissport S. Rapid high performance liquid chromatographic assay for total homocysteine in human serum. J Chromatogr 1991;565:441-6.
15. Southern FN, Cruz N, Fink LM, et al. Hyperhomocysteinemia increases intimal hyperplasia in a rat carotid endarterectomy model. J Vasc Surg 1998;28:909-18.
16. Herbert JM, Bernat A, Maffrand JP. Importance of platelets in experimental venous thrombosis in the rat. Blood 1992;80: 2281-6.
17. De La Cruz P, Arrebola M, Gonzalez-Correa A, et al. Effects of clopidogrel and ticlopidine on experimental diabetic ischemic retinopathy in rats. Naunyn Schmiedebergs Arch Pharmacol 2003;367:204-10.
18. Harker LA, Marzec UM, Kelly AB, et al. Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates. Circulation 1998;98:2461-9.
19. Matasagas M, Jagroop IA, Geroulakos G. The effect of a loading dose (300 mg) of clopidogrel on platelet function in patients with peripheral arterial disease. Clin Appl Thromb Hemost 2003; 9:115-20.
20. Coller BS, Folts JD, Scudder LE, et al. Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model. Blood 1986;68:783-6.
21. Gurbel PA, Bliden KP, Hiatt BL, et al. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003;107:2908-13.
22. Grau AJ, Reiners S, Lichy C, et al. Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study. Stroke 2003;34:849-54.
23. CAPRIE Steering Committee. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.
24. Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
25. Jackson MR, Clagett GP. Antithrombotic therapy in peripheral arterial occlusive disease. Chest 2001;119 Suppl 1:283S-99S.
26. Pasqualini L, Pirro M, Lombardini G, et al. A human model of platelet-leucocyte adhesive interactions during controlled ischaemia in patients with peripheral vascular disease. J Clin Pathol 2002;55:946-50.